These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 16371014)
1. Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*. Thursky KA; Worth LJ; Seymour JF; Miles Prince H; Slavin MA Br J Haematol; 2006 Jan; 132(1):3-12. PubMed ID: 16371014 [TBL] [Abstract][Full Text] [Related]
9. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Martin SI; Marty FM; Fiumara K; Treon SP; Gribben JG; Baden LR Clin Infect Dis; 2006 Jul; 43(1):16-24. PubMed ID: 16758413 [TBL] [Abstract][Full Text] [Related]
10. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. Laros-van Gorkom BA; Huisman CA; Wijermans PW; Schipperus MR Neth J Med; 2007 Oct; 65(9):333-8. PubMed ID: 17954952 [TBL] [Abstract][Full Text] [Related]
11. Alemtuzumab in Sézary syndrome: efficient but not innocent. Ure UB; Ar MC; Salihoglu A; Guner SI; Baran A; Oguz O; Ferhanoglu B Eur J Dermatol; 2007; 17(6):525-9. PubMed ID: 17951134 [TBL] [Abstract][Full Text] [Related]
16. Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T-cell lymphoproliferative disorders. Gibbs SD; Westerman DA; McCormack C; Seymour JF; Miles Prince H Br J Haematol; 2005 Jul; 130(1):87-91. PubMed ID: 15982349 [TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. Alinari L; Lapalombella R; Andritsos L; Baiocchi RA; Lin TS; Byrd JC Oncogene; 2007 May; 26(25):3644-53. PubMed ID: 17530018 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of alemtuzumab in chronic lymphoproliferative disorders. Ferrajoli A; O'Brien SM; Cortes JE; Giles FJ; Thomas DA; Faderl S; Kurzrock R; Lerner S; Kontoyiannis DP; Keating MJ Cancer; 2003 Aug; 98(4):773-8. PubMed ID: 12910522 [TBL] [Abstract][Full Text] [Related]